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Summary
Objective: The present study aimed to determine the role of excitatory amino acids (EAAs) and EAA transporters (EAATs) in an osteoarthritis
(OA) model of rabbit knees.
Methods: OA was induced in New Zealand white male rabbits by anterior cruciate ligament transection (ACLT) in one knee of one hind limb;
the other knee left unoperated. Rabbits that received ACLT of knee were assigned to the ACLT group (n¼ 6), while a sham-operated group
(n¼ 6) underwent arthrotomy with no ACLT. Six na€ıve rabbits that received no surgery were used as normal control. The width of the knee
joint was measured to determine the severity of joint inﬂammation. Before operation and at 10, 20, and 30 weeks after operation, knee joint
dialysates were collected by microdialysis and assayed for EAAs by high-performance liquid chromatography. Gross morphology and histo-
pathology and EAATs glutamate/aspartate transporter (GLAST) and glutamate transporter-1 (GLT-1) expression in the articular cartilage of
the knees were evaluated by immunohistochemistry and western blot analysis.
Results: In the ACLT knees, a signiﬁcant increase in the joint width was observed (5.3 0.9 mm, P< 0.05) at 30 weeks after operation, while
the sham-operated and na€ıve knees showed no difference as compared with the basal values. The concentrations (mM) of aspartate and glu-
tamate in knee dialysates at 30 weeks after ACLT in na€ıve, sham, and ACLT were 0.36 0.07 and 4.5 1.10; 0.38 0.09 and 4.61 1.11;
0.67 0.18 and 9.71 2.89, respectively. Levels of glutamate and aspartate in the dialysates obtained from the ACLT knees increased by
213.3 29.6% and 187.5 33.8% (P< 0.05) when compared to those in the sham-operated knees. Both na€ıve and ACLT chondrocytes
were positively stained by antibodies against GLAST and GLT-1. GLAST and GLT-1 protein expressions were signiﬁcantly increased in
the ACLT knees (P< 0.05).
Conclusion: Our ﬁndings indicate an involvement of EAAs and EAATs in the pathogenesis of OA in ACLT rabbits.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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1442Introduction
Osteoarthritis (OA) is the most prevalent form of arthritis in
the United States and is often associated with signiﬁcant
disability and impaired quality of life1. OA is a synovial joint
disorder that is characterized by the destruction of the
articular cartilage accompanied by inﬂammation2,3. Patients
with rupture of the anterior cruciate ligament (ACL) develop
post-traumatic OA of the knee4. Restoration of knee stability
provides symptomatic relief but does not reduce the
1443Osteoarthritis and Cartilage Vol. 16, No. 12degenerative changes in the ACL-injured knee5. This
suggests that the development of post-traumatic OA not
only has a biomechanical origin but may also involve
biochemical changes.
Glutamate is a well-known excitatory neurotransmitter in
the mammalian central nervous system (CNS), being
responsible for up to one-third of the excitatory synaptic func-
tions6. Growing evidence indicates that glutamate also plays
a role in cell signaling in peripheral tissues such as the
bone7e9. Glutamate increases in the innervated axons of in-
ﬂamed knee joints10 and the synovial ﬂuid of arthritic pa-
tients11. The injection of a kaolin/carrageenan mixture into
the knee joint induces an immediate increase in the gluta-
mate and aspartate levels in the joint; this increase persists
for hours12. We previously reported that glutamate and as-
partate levels are signiﬁcantly increased in the dialysates
of ACLT rat knees and suggested that excitatory amino acids
(EAAs) play a role in early OA development13. The physio-
logical extracellular concentration of glutamate is regulated
by the action of high-afﬁnity, sodium-dependent EAA trans-
porters (EAATs)6. EAATs are the key mechanism for the
clearance and maintenance of extracellular glutamate con-
centrations at excitatory synapses and thus for the termina-
tion of glutamate signaling. At least ﬁve EAATs have been
identiﬁed6,14. Glutamate/aspartate transporter (GLAST,
EAAT1), glutamate transporter-1 (GLT-1, EAAT2), EAA
carrier 1 (EAAC1, EAAT3), EAAT 4 (EAAT4), and EAAT5.
Mason et al. ﬁrst demonstrated glutamate signaling and
downregulation of GLAST mRNA by mechanical loading in
rat bone15. Mechanical regulation of neural EAATs expres-
sion has recently been described in bones, suggesting that
EAAs play a role in paracrine intercellular communication15.
Over the last few years, a small but growing number of re-
searchers have provided increasing evidence to support
the role of glutamate as an important mediator of bone cell
functions7,8. Thus far, however, little attention has been
paid to EAAT expression in the knee joint and its role in
OA development. The present study, using the ACLT rabbit
model, examined the concentration change in EAAs during
OA development and the concomitant expression of GLAST,
GLT-1, and EAAC1 in the articular cartilage of the knee
joints.MethodsANIMAL MODELThe use of animals conformed to the Guiding Principles in the Care and
Use of Animals of the American Physiology Society and was approved by
the Animal Care and Use Committee of the National Sun Yat-Sen University,
Taiwan. A total of 25 healthy New Zealand white adult male rabbits (body
weight: 1530e1620 g) were used in this study. OA was induced in New
Zealand white male rabbits via ACL transection (ACLT) in one knee of one
hind limb; the other knee was left unoperated. Rabbits that received ACLT
were assigned to the ACLT group (n¼ 6), while the sham-operated group
(n¼ 6) underwent arthrotomy with no ACLT. Six na€ıve rabbits that received
no surgery were used as normal control. For the sham operation, the ACL of
the knee was exposed but not transected. This procedure was modiﬁed from
the protocol described by Stoop et al.16. Rabbits were allowed daily
unrestricted cage activity after surgery. Wound healing and infection or
any other complications were monitored continuously during the 30-week
observation period.CONSTRUCTION AND PLACEMENT OF THE MICRODIALYSIS
PROBEA microdialysis probe was implanted in each rabbit knee joint under iso-
ﬂurane anesthesia for joint dialysate collection before (baseline) and at 5,
10, 20, and 30 weeks after the ACLT or sham operation. The construction
and placement of the microdialysis probe were done according to ourprevious reports13,17. For the in vitro measurement, the average recovery
rate of the dialysis probe was 19.5 5.2% at an infusion rate of 1.5 mL/min
of eight different microdialysis probes. All samples were collected in polypro-
pylene tubes, kept on ice, and then frozen at 80C until assayed.MEASUREMENT OF EAAsHigh-performance liquid chromatography (HPLC) with a ﬂuorescence
detector (pump 126, Beckman Instruments Inc., Fullerton, CA, USA) was
used. The protocol for EAA detection was according to our previously
described methods18. External standards containing 0, 108, 107, 106,
or 105 M standard amino acids were run before and after each sample
group. The detection sensitivity was 108 M. All standards and samples
were analyzed in duplicate.INFLAMMATION, GROSS MORPHOLOGY, AND
HISTOPATHOLOGICAL EXAMINATIONS OF KNEE JOINTSThe severity of knee joint inﬂammation was reﬂected by an increase in the
hind limb knee joint width. The width of the bilateral hind limb knee joints was
measured from the medial to the lateral aspect of the joint line by using
calipers before (baseline) and at 5, 10, 15, 20, 25, and 30 weeks after
operation. At week 30 after surgery and microdialysis sample collection,
the rabbits were sacriﬁced, and the rabbit knees were disarticulated immedi-
ately after death. Gross morphologic changes in the cartilage of the medial
femoral condyle were examined according to previously described
methods19,20. The joints were cut 0.5 cm above and below the joint line, ﬁxed
in 10% neutral buffered formalin for 3 days, and then decalciﬁed for 2 weeks
in buffered 12.5% ethylene diamine tetraacetic acid (EDTA)/formalin
solution. The joints were cut in the mid-saggital plane, washed in running
tap water, and parafﬁn-embedded in an automatic processor (Autotechnicon
mono 2, Technion Co., Chauncey, NY, USA). Serial articular cartilage
sections (2 mm) were cut using a microtome (Microm HM340E, Walldorf,
Germany) from the central weight-bearing surface of the medial femoral
condyles of the ACLT, sham-operated, and na€ıve knees. Cartilage was
stained with hematoxylin/eosin (H/E) and safranin-O/fast green stains to
assess general morphology and matrix proteoglycans. Microscopic examina-
tion of the articular cartilage in the medial femoral condyles was graded
according to the Mankin’s grading system21. A representative specimen of
the synovial membrane from the medial and lateral compartments of the
knee was dissected from the underlying tissues for histological examination,
as previously described22.IMMUNOHISTOCHEMISTRY FOR EAATsCartilage specimens were processed for immunohistochemistry, as
described previous23. Sections (2 mm) of parafﬁn-embedded specimens
were placed on slides, deparafﬁnized with xylene, dehydrated in graded
series of ethanol, and the endogenous peroxidase activity was quenched by
30 min of incubation in 0.3% H2O2 in methanol at room temperature. The an-
tigen was retrieved by enzymatic digestion with proteinase K (Sigma; 20 mM)
in phosphate buffered saline (PBS) for 20 min at room temperature in a humid
chamber. The slides were incubated with the primary antibody against either
GLAST (1:100 dilution; Chemicon) or GLT-1 (1:50 dilution; BD Biosciences
Pharmingen) in 0.3% Triton X-100 in PBS overnight at 4C in a humidiﬁed
chamber. Thereafter, sections were treated with avidinebiotin complex
(ABC) technique using the ABC kit (Vectastain ABC kit; Vector, Burlingame,
CA, USA). Sections from the negative control samples were incubated with
PBS without antibody. The images were viewed using a Leica DM-1000
microscope (Leica, Heidelberg, Germany) and captured using a SPOT CCD
RT-slider integrating camera (Diagnostic Instruments Inc., USA).WESTERN BLOT ANALYSIS FOR EAATsRabbits were anesthetized with isoﬂurane, and full-thickness pieces of the
articular cartilages of the tibial plateau and femoral condyle were removed
aseptically from the subchondral bone with a scalpel, washed with iced
PBS, and cut into small pieces with scissors. The cartilage was homoge-
nized in ice-cold lysis buffer (50 mM Tris at pH 7.5, 150 mM NaCl, 2% Triton
X-100, 100 g/mL phenylmethylsulfonyl ﬂuoride, and 1 mg/mL aprotinin) by
using a rotor/stator homogenizer (2000 rpm, three times for 10 s each). All
samples were then sonicated three times using a Microson ultrasonic cell
disruptor (Heat Systems, Farmingdale, NY, USA) for 15 s each at 20%
output power. The homogenates were centrifuged at 50,000g (TXL-100,
Beckman, USA) for 30 min at 4C. For EAAT analysis, a 50 mg cartilage ho-
mogenate sample was obtained. In brief, an equal volume of sample buffer
[2% sodium dodecyl sulfate (SDS), 10% glycerol, 0.1% bromophenol blue,
2% 2-mercaptoethanol, and 50 mM TriseHCl at pH 7.2] was added to the
sample, which was then loaded onto a 10% SDSepolyacrylamide gel, and
Table I
Macroscopic evaluation of the articular cartilage of the medial
femoral condyles
Group Score
ACLT (n¼ 6) 2.68 0.32*
Sham (n¼ 6) 0.15 0.02
Na€ıve (n¼ 6) 0.12 0.01
Data are expressed as meanSD. ACLT, rabbits that under-
went ACLT of the knee; sham, rabbits that only underwent arthrot-
omy of the knee; na€ıve, normal control rabbits that did not undergo
any surgery.
*P< 0.05 when compared with the sham-operated and na€ıve
groups.
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ferred to a polyvinylidene diﬂuoride membrane (0.45 M pore size, Immobilon-
P; Millipore) at 125 mA overnight at 4C in a transfer buffer (50 mM TriseHCl,
380 mM glycine, 1% SDS, and 20% methanol); thereafter, the membrane
was blocked for 50 min at room temperature with 5% non-fat dry milk in
0.1% Tween-20 in 20 mM TriseHCl and 137 mM NaCl at pH 7.4 Tris Tween
Buffer Saline (TTBS), and incubated for 180 min at room temperature with
antibodies against GLAST (EAAT1, 1:1000 dilution; Chemicon, Temecula,
CA, USA), GLT-1 (EAAT2, 1:1000 dilution; BD Biosciences Pharmingen),
and EAAC1 (EAAT3, 1:1000 dilution; Chemicon, Temecula, CA, USA). Im-
munoblotting was then performed using appropriate antibodies and then
with horseradish peroxidase (HRP)-conjugated secondary antibody (Jack-
son Immuno Research Laboratories Inc., USA). The immunoreactive bands
were visualized by enhanced chemiluminescence (ECL kit; Millipore, Bed-
ford, MA, USA), and then the images were visualized using the UVP Bio-
Chemi Imaging System. Relative densitometric quantiﬁcation was then
performed using LabWorks 4.0 software (UVP, Upland, CA, USA). The rela-
tive variations between the bands of the various treatment samples and the
control group (right side of the na€ıve knee) were calculated using the same
image.DATA AND STATISTICAL ANALYSISAll data are presented as the mean standard deviation (SD) and were
analyzed by one-way analysis of variance (ANOVA) according to the
StudenteNewmaneKeuls post hoc test for multiple comparisons. For the
immunoreactivity data, the intensity of each test band was expressed as
the integrated optical density. A signiﬁcant difference was deﬁned as
a P value of <0.05.ResultsKNEE JOINT WIDTH AND GROSS MORPHOLOGICAL CHANGESThe severity of knee inﬂammation, reﬂected by an
increase in the width of the hind limb knee joint, was signif-
icant at 5, 10, 15, 20, 25, and 30 weeks after the surgery in
the ACLT knee group. In the ACLT knees, the joint width
was 5.3 0.9 mm greater than the contralateral knee at
30 weeks after the operation, while the sham-operated
knees and the na€ıve knees exhibited no signiﬁcant change
in this regard (Fig. 1, P< 0.05). In the articular cartilage of
the ACLT knees, an edematous change was observed, ac-
companied by mild focal ﬁbrillation and pitting and thinning
of the medial femoral condyle. Osteophytes were visible in
all femoral condyles and tibial plateaus in the ACLT knee
joints at 30 weeks after surgery. The macroscopic scores
were 2.68 0.78 in the ACLT group (Table I). In the
sham-operated and na€ıve knees of the rabbits, the cartilageTime after ACL transection (week)
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Fig. 1. Time-course of joint width changes after operation. In the
ACLT knees, the joint width at 30 weeks after surgery was
5.3 0.4 mm greater than its baseline value, while it did not change
signiﬁcantly in the sham-operated and na€ıve knees (P< 0.05).on the medial femoral condyles was normal, with a glisten-
ing translucent smooth surface, and no cartilage defects or
osteophytes were observed; the macroscopic scores were
0.15 0.04 and 0.12 0.02, respectively (Table I). Signiﬁ-
cant differences in the macroscopic scores were observed
between the ACLT knees and both the sham-operated
and na€ıve knees (Table I). The synovium exhibited conges-
tion and inﬂammation in the ACLT knees, but no hyperemia
or evidence of synovitis was observed in the sham-oper-
ated and na€ıve knees.MICROSCOPIC FINDINGSSpecimens obtained from the ACLT knees exhibited focal
ﬁbrillation extending through the superﬁcial zone up to the su-
perﬁcial zoneemid zone region. Moreover, loss of safranin-
O/fast green staining in the calciﬁed cartilage layer and cleft,
depletion of chondrocytes in the cartilage layer, hyperplasia
of chondrocytes, and irregularity of the bony trabeculum at
the junction between the calciﬁed cartilage and subchondral
layer were observed in the ACLT knees. In the sham-oper-
ated and na€ıve knees, the histological appearance of theme-
dial femoral condyles was normal; the cartilage surface was
smooth with no superﬁcial zone discontinuity. The matrix
and associated chondrocytes were organized into three ap-
propriately oriented, well-ordered zones. No enlargement,
distortion, or proliferative changes were observed in the
chondrocytes. Further, preservation of safranin-O/fast green
staining, normal chondrocytes in the calciﬁed cartilage layer,
and smooth bony trabeculum in the subchondral layer were
observed. Signiﬁcant differences in the histological Mankin
score for OA were observed between the ACLT knees
(8.50 0.93) and both the sham-operated (1.83 0.62)
and na€ıve knees (1.20 0.53) (P< 0.05) (Table II). The
synovium of the ACLT knees was thick with focal villi andTable II
Histological evaluation of the articular cartilage of the medial femo-
ral condyles and synovial tissue
Osteoarthritic score Synovitis score
ACLT (n¼ 6) 8.50 0.38* 9.50 0.60*
Sham (n¼ 6) 1.83 0.42 2.01 0.26
Na€ıve (n¼ 6) 1.20 0.22 1.83 0.34
Data are expressed as meanSD. ACLT, rabbits that under-
went ACLT of the knee; sham, rabbits that only underwent arthrot-
omy of the knee; na€ıve, normal control rabbits that did not undergo
any surgery. For details on the osteoarthritic score (Mankin score)
and the synovitis score, refer to the Methods.
*P< 0.05 when compared with the sham-operated and na€ıve
groups.
Table III
Basal concentration of aspartate (Asp) and glutamate (Glu) in knee dialysates of each group at baseline, 10th, 20th, and 30th week after
surgery
Time after surgery Na€ıve/L Sham ACLT
Asp Glu Asp Glu Asp Glu
Baseline 0.35 0.08 4.11 1.24 0.36 0.09 4.16 1.08 0.37 0.08 4.23 1.15
10th 0.38 0.08 4.36 1.13 0.38 0.08 4.44 1.12 0.50 0.11 6.27 1.95
20th 0.37 0.08 4.37 1.02 0.38 0.07 4.31 1.11 0.59 0.16 7.91 2.52
30th 0.36 0.07 4.50 1.10 0.38 0.09 4.61 1.11 0.67 0.18 9.71 2.89
Data are expressed as meanSD (mM) of six rabbits. Na€ıve/L: left knee of na€ıve rats.
1445Osteoarthritis and Cartilage Vol. 16, No. 12exhibited hyperplasia of the lining cells, withmoderatemono-
nuclear cell inﬁltration. The histology of the synovium was
normal in the sham-operated and na€ıve knees. The synovitis
scores are shown in Table II; the score was signiﬁcantly
higher in the ACLT group (9.50 1.47, P< 0.05) than in
both the sham-operated (2.01 0.64) and na€ıve groups
(1.83 0.83) (Table II).*
Aspartate
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Glutamate
BTable III shows the concentration of aspartate and
glutamate in the knee dialysates of baseline (before
surgery) and at 10, 20, and 30 weeks after surgery in the
knees of na€ıve, sham, and ACLT groups. No signiﬁcant
difference was observed in the baseline level of EAAs
among the three groups. For statistics analysis consider
the aspartate and glutamate level in the contralateral knee
as the 100% control. As shown in Fig. 2, at week 30 after
the ACLT surgery, the levels of aspartate and glutamate
in the ACLT knee dialysates were 187.5 33.8% and
213.3 29.6%, respectively (considering the corresponding
levels in the contralateral knee as 100%). A signiﬁcant
increase in the glutamate level was observed in the ACLT
knees (213.3 29.6%) (P< 0.05) when compared with
that in the sham-operated knees [Fig. 2(B)]. In brief, from
week 10 to week 30 after surgery, both the aspartate and
glutamate levels were signiﬁcantly increased in the joint
dialysates of the ACLT knees when compared with these
in the sham-operated knees (P< 0.05). No difference was
observed in the aspartate and glutamate concentrations
between the right and left na€ıve knees, and between na€ıve
and sham-operated joints (data not shown).100
IMMUNOHISTOCHEMISTRY OF EAATsTime after ACL transection (week)
0 10 20 30
0
50
Fig. 2. The EAA levels in the knee joint dialysates were measured
at 0 (baseline), 5, 10, 20, and 30 weeks after the surgery. The level
in the contralateral knee was considered as 100%. A signiﬁcant in-
crease in the glutamate level was observed in the ACLT knees
(213.3 29.6%, P< 0.05) when compared with that in the sham-The immunolocalization of GLAST and GLT-1 protein
expression in cartilage specimens from na€ıve and ACLT
groups were examined. As shown in Fig. 3, GLAST and
GLT-1 were located in chondrocytes of the superﬁcial and
transitional zones of na€ıve and ACLT knees. Figure 3(A
and B) shows the staining of GLAST and GLT-1 expression
in na€ıve knees, while Fig. 3(C and D) shows the staining of
GLAST and GLT-1 expression in the ACLT knees. From the
four individual observations, we found that no staining was
observed in the negative control [Fig. 3(E and F)]. Both
na€ıve and ACLT chondrocytes were positively stained
with antibodies against GLAST and GLT-1.operated knees. The difference in the aspartate concentration
was also signiﬁcant between the ACLT knees and the sham-oper-
ated knees (187.5 33.8%). Both the aspartate (A) and glutamate
(B) levels increased signiﬁcantly from week 10 to week 30 after the
surgery in the knee joint dialysates of the ACLT knee (P< 0.05)EFFECTS OF ACLT ON THE GLAST AND GLT-1 PROTEIN
EXPRESSIONS IN ARTICULAR CARTILAGE OF RABBIT
KNEE JOINTS
when compared with the sham-operated knees. *P< 0.05 when
compared with those in the sham-operated knee; L, left side of
the na€ıve knee.
As shown in Fig. 4(A), the expression of GLAST and
GLT-1 proteins in knee cartilage homogenates (50 mg)was analyzed by western blot of na€ıve (right and left knees),
sham and ACLT knees at week 30 after surgery. The
GLAST antibody exhibited a band atw55 kDa (open arrow)
and the GLT-1 exhibited a band atw54 kDa (closed arrow).
Figure 4(B and C) shows that the quantiﬁcation of GLAST
and GLT-1 protein expression. The GLAST protein
Fig. 3. The distribution of GLAST and GLT-1 protein immunoreactivity in the cartilage of control and ACLT knees. Positive immunoreactivity of
GLAST and GLT-1 is indicated by red-brown color. The distribution of anti-GLAST (A) and anti-GLT-1 (B) immunoreactivity of control cartilage;
(C) and (D) were ACLT knees stained with antibodies against GLAST and GLT-1, respectively. GLAST positive (arrows) and GLT-1 positive
(asterisks) chondrocytes are indicated, including enlarged views of the respective surface zones as insets. The knee joint sections incubated
without primary antibody for GLAST (E) or GLT-1 (F) showed no speciﬁc staining in the control group. Scale bar¼ 100 mm.
1446 Y.-H. Jean et al.: Excitatory amino acids and excitatory amino acid transporters in OA kneesexpression signiﬁcantly increased in the cartilage of the
ACLT and the sham-operated knees when compared with
that in the na€ıve (both right and left) knees (P< 0.05). More-
over, the GLAST protein expression was signiﬁcantly higher
in the ACLT knees than in the sham-operated knee
[Fig. 4(B)]. As observed in Fig. 4(C), GLT-1 expression
was only signiﬁcantly upregulated in the cartilage of the
ACLT knees when compared with that in the sham-oper-
ated and na€ıve (both right and left) knees. No difference
in the GLAST and GLT-1 protein expressions was observed
between the right and left knees of the na€ıve rabbits. In thepresent study, EAAC1 protein expression was not observed
in the cartilage of any of the knees.
Discussions
The present study conﬁrmed that OA developed 30
weeks following ACLT in rabbits, and a concomitant
increase in the glutamate and aspartate concentrations
released was observed in the ACLT knees but not in the
sham-operated knees. Both na€ıve and ACLT chondrocytes
were positively stained with antibodies against GLAST and
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Fig. 4. Western blots of GLAST and GLT-1 (A) in various knee cartilage extracts. The knee cartilages were collected at 30 weeks after ACLT
surgery. Lanes show samples from right side of the na€ıve knee (lane no. 1), left side of the na€ıve knee (lane no. 2), sham-operated knee (lane
no. 3), and ACLT knee (lane no. 4). The GLAST antibody exhibited a band at w55 kDa (closed arrow) and the GLT-1 exhibited a band at
w54 kDa (open arrow). The densitometric quantiﬁcations for GLAST (B) and GLT-1 (C) were normalized to that for total loading protein
(50 mg) from knee cartilage homogenates, and each bar represents the meanSD of ﬁve independent experimental results. *P< 0.05
when compared to the right knee of the na€ıve rabbits; #P< 0.05 when compared to the sham-operated knees. R¼ right side of the na€ıve
knee; L¼ left side of the na€ıve knee. Bands marked with * in (A) are non-speciﬁc binding of secondary antibody.
1447Osteoarthritis and Cartilage Vol. 16, No. 12GLT-1. More importantly, we observed changes in the
EAAT expression in the articular cartilage of the ACLT
knees. As compared to the sham-operated and na€ıve
knees, the GLAST and GLT-1 protein expression increased
signiﬁcantly in the articular cartilage of the ACLT knees. To
our knowledge, this paper is the ﬁrst study to directly
demonstrate the functional expression of speciﬁc EAATs
in articular cartilage in relation to the pathogenesis of OA
following ACLT of the knees in an animal model.
It is well-known that knee instability following a complete
ACL tear often induces OA and is accompanied by
degradation of the articular cartilage matrix22. Consistent
with our previous study13,17, OA developed in the rabbits
30 weeks following ACLT in the present study. Synovial
inﬂammation was observed to play an important role in OA
progression2,3. The mild-to-moderate inﬂammatory changes
observed in the synovium of the ACLT knees in our study
(Table II) were compatible with those observed in previous
studies13,17,24. Previous studies have demonstrated a drastic
increase in endogenous glutamate levels (6.25 vs 326 mM)
in the synovial ﬂuid obtained from the knees of rheumatoid
arthritis (RA) patients11, whereas the elevation of glutamate
in the synovial ﬂuid was shown to be relevant to the edema
and the thermal hyperalgesia in experimental arthritismodels12,25. In our present study, the increase in the knee
joint width indicated an increase in inﬂammation with time
(Fig. 1), and a corresponding increase in the amount of
synovial ﬂuid and the concentrations of glutamate and
aspartate in the joint dialysates of ACLT knees (Fig. 2).
Glutamate has been detected in the network of nerve ﬁ-
bers transversing the bone marrow as well as in osteo-
blasts, where it may be released due to exocytosis26,27.
OA-associated pain may arise due to glutamate release
from the axons innervating the inﬂamed region28. Flood
et al. demonstrated that MK-801 (a non-competitive antag-
onist of N-methyl-D-aspartate (NMDA) receptors) in RA ﬁ-
broblast-like synoviocytes induced an increase in matrix
metalloproteinase-2 release, whereas non-NMDA iono-
tropic glutamate receptor antagonist 2,3-dihydroxy-6-nitro-
7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBOX) inhibited
interleukin-6 production; this suggested that glutamate re-
ceptor antagonist may inﬂuence the RA pathology29. More-
over, glutamate receptor antagonists inhibit the proliferation
of synovial ﬁbroblasts, suggesting that these antagonists
exert a disease-modifying effect on synovial proliferation
occurring in RA30. In the present study, from week 10 to
week 30 after ACLT, increased levels of EAA glutamate
and aspartate were observed in the ACLT knee dialysates
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sates; this is consistent with our previous study, where early
OA development occurred 20 weeks after the ACLT with
a concomitant increase in the glutamate and aspartate con-
centrations in the ACLT knees but not in the sham-operated
knees of Wistar rats13. These biochemical changes with re-
gard to the EAAs elevation in the dialysates of ACLT knees
are contribute to the pathogenesis of OA.
EAATs are known to be responsible for maintaining the
homeostasis of the extracellular glutamate concentration;
theyprotect neurons against harmful overstimulation of gluta-
matergic receptors31. Glutamate cytotoxicity is only evident
at a high concentration of 10 mM32. Genever et al. have
previously demonstrated that osteoblasts express GLAST
and rapidly accumulate [3H]-glutamate; this provides a possi-
blemolecularmechanism for intracellular glutamate accumu-
lation32. In our present study, by immunohistochemistical
analysis, we found an expression of EAAT isoforms (GLAST
and GLT-1) in the chondrocytes of na€ıve and ACLT cartilage
(Fig. 3). Cultural rat costal chondrocytes were demonstrated
to express the glial EAAT GLT-133. To our knowledge, this is
the ﬁrst report of the EAAT protein expression in chondro-
cytes of na€ıve and ACLT-induced OA knee cartilage. Our
results conﬁrm EAAT expression in chondrocytes. The
molecular weights of GLAST and GLT-1 proteins in the
CNS were different from those reported in the previous stud-
ies;GLASTandGLT-1 immunoreactive bandsweredetected
at 66e70 kDa and 65e70 kDa, respectively, in the neuronal
tissue34,35. In the present study,we found thatGLASTprotein
expression signiﬁcantly increased in the cartilage of the
ACLT and sham-operated knees when compared with that
in the na€ıve knees [Fig. 4(B)]; the immunoreactive bands of
GLAST and GLT-1 were found at w55 kDa and w54 kDa,
respectively. Several studies have demonstrated that the
molecular weights of GLAST and GLT-1 range from 65 to
70 kDa and 54 to 55 kDa, which correspond to their glycosy-
lated and non-glycosylated forms, respectively36e39. Danbolt
et al.37 and Raunser et al.38 also found a 73 kDa band
corresponding to glycosylatedGLT-1 and a 55 kDa band cor-
responding to non-glycosylated GLT-1. Moreover, Conradt
et al.39 also revealed a 65 kDa band corresponding to the gly-
cosylated GLAST and a 56 kDa band for the non-glycosy-
lated GLAST. Both the glycosylation and non-glycosylation
of GLAST and GLT-1 did not affect the transport activi-
ties38,39. Another possibility of the differentmolecularweights
of EAATs (GLAST and GLT-1) is splice variant. A splice
variant of GLAST, namely, GLAST-1a, lacking of exon-3 is
expressed in the bone and brain, and its non-glycosylated
form has a molecular weights of 54 kDa40. Moreover, the
exon-9 skipping form of GLAST-1b expresses predominantly
in the plasma membrane of apparently abnormal
neurons41,42. It suggested that the equivalent exon-9
skipping form of GLAST (GLAST-1b) is a negative effector
of function. The exon-9 skipping form of GLT-1 was cloned
from human tissues43e45 and was initially described selec-
tively present in the brain of patients with motor neuron
disease of amyotrophic lateral sclerosis, and this splice vari-
ant was a causal factor for the pathogenesis of this disease43.
In our present study, from the result of western blot analysis, it
was suggested that both GLAST and GLT-1 proteins
expressed in cartilage were not glycosylated.
It is interesting that an increase in GLAST expression
was observed in sham-operated knees as compared to
na€ıve knees in our present study; the reason for this feature
is yet unclear and requires further investigation. Among the
EAAT subtypes, both GLAST and GLT-1 mRNA and pro-
teins have been demonstrated in bone, while the EAAC1immunoreactivity is absent15,40,46. However, by the immu-
nohistochemical analysis, EAAC1 protein expression was
found in the synovial tissue47. In contrast, our present study
failed to demonstrate the protein expression of EAAC1 in
the knees of all examined rabbits. Collectively, our ﬁndings
suggest the possibility of a compensatory mechanism of
glutamatergic signaling pathways for this increase in
EAAT isoform expression and EAA release in the articular
cartilage of OA knees. However, the roles of GLAST and
GLT-1 in this regard remain unclear. Our present results
do not exclude the contribution of other biological
substances to the development of OA in ACLT knees.
In conclusion, our results show that OA of the knee is
observed in rabbits at 30weeks after ACLT.Anassociated in-
crease observed in the glutamate and aspartate levels in the
dialysates of the ACLT kneesmay be involved in the process
of OA development. Furthermore, an increase in GLAST and
GLT-1 expressions in theACLT knee cartilagewas also dem-
onstrated in immunohistochemistry and western blot data.
Understanding the role of glutamate and the regulation of
its uptake in animal models of ACLT-inducedOAwill be help-
ful for elucidating the mechanisms underlying the pathogen-
esis of OA and for developing new therapeutic strategies.
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